181308-57-6 Usage
Description
TERT-BUTYL TRANS-4-FORMYLCYCLOHEXYLCARBAMATE is a white to light yellow solid that serves as an intermediate in the pharmaceutical industry. It is a compound with specific chemical properties that make it valuable for the development and synthesis of various pharmaceutical products.
Uses
Used in Pharmaceutical Industry:
TERT-BUTYL TRANS-4-FORMYLCYCLOHEXYLCARBAMATE is used as an intermediate for the synthesis of pharmaceutical compounds. Its unique chemical structure allows it to be a key component in the development of new drugs and medications, contributing to the advancement of medical treatments and therapies.
As an intermediate, TERT-BUTYL TRANS-4-FORMYLCYCLOHEXYLCARBAMATE plays a crucial role in the chemical reactions and processes involved in the production of various pharmaceuticals. Its application in this industry is essential for the creation of new and improved medications that can address a wide range of health issues and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 181308-57-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,1,3,0 and 8 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 181308-57:
(8*1)+(7*8)+(6*1)+(5*3)+(4*0)+(3*8)+(2*5)+(1*7)=126
126 % 10 = 6
So 181308-57-6 is a valid CAS Registry Number.
181308-57-6Relevant articles and documents
CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
-
, (2022/01/12)
Provided herein are piperidine dione compounds having the following structure: wherein R1, R2, R3, R4, L, V, X, A, A′, a and m are as defined herein, compositions comprising an effective amount of a piperidine dione compound, and methods for treating or preventing an androgen receptor mediated disease.
CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
-
, (2022/01/04)
Provided herein are piperidine dione compounds having the following structure: wherein RN, R1, R2, R3, R4, RN, L, V, X, a, m, and n are as defined herein, compositions comprising an effective amount of a piperidine dione compound, and methods for treating or preventing an androgen receptor mediated disease.
FUSED PYRIDINES WHICH ACT AS INHIBITORS OF H-PGDS
-
Page/Page column 66, (2019/07/19)
A compound of formula (I) wherein R1, R2, R3, R4 χ γ anc| A are as defined herein. The compounds of the present invention are inhibitors of hematopoietic prostaglandin D synthase (H-PGDS) and can be useful in th
